Blueprint Medicines Corporation (NASDAQ:BPMC): Are Analysts Optimistic?

By Yahoo! Finance | Oct 27, 2024 at 09:58 AM EST

Blueprint Medicines Corporation is a precision therapy company developing medicines for cancers and blood disorders. Analysts predict the company to break even by 2026 with an expected annual growth rate of 68%. However, its high debt-to-equity ratio poses a risk for investors.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.